| 2017 | | Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma | 김순선, 김진우, 노충균, 신성재, 양민재, 원제환, 이기명, 정재연, 조성원, 조효정, 지재훈 |
| 2018 | | Plasma MicroRNA-21, 26a, and 29a-3p as Predictive Markers for Treatment Response Following Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma | 김보현, 김순선, 김재근, 김진우, 김현지, 원제환, 이제희, 정재연, 조성원, 조효정 |
| 2010 | | Prediction of compensated liver cirrhosis by ultrasonography and routine blood tests in patients with chronic viral hepatitis | 김재근, 정재연, 조성원 |
| 2012 | | Revision and update on clinical practice guideline for liver cirrhosis | 김재근, 정재연, 조성원 |
| 2005 | | Survival benefits of intra-arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis. | 김재근, 김진홍, 왕희정, 원제환, 이기명, 정재연, 조성원, 함기백 |
| 2007 | | The Effect of Preoperative Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma | 김명욱, 김봉완, 김영배, 박용근, 왕희정, 원제환, 조성원 |
